Literature DB >> 1392339

Coronary artery bypass grafting in patients with depressed left ventricular function: operative results and long-term follow-up.

S Sekine1, R Kuribayashi, T Sakurada, H Aida, H Atsumi, T Abe.   

Abstract

Nine consecutive patients with coronary artery disease who had a left ventricular ejection fraction (LVEF) of less than 0.4 and underwent coronary artery bypass grafting (CABG) at our institution were studied. All patients had angina pectoris and six of the nine patients (67%) had a history of congestive heart failure. The mean EF was 0.37 +/- 0.03 and the mean LV end-diastolic pressure was 10.1 +/- 4.9 mmHg. An average of 1.56 +/- 0.50 grafts per patient were placed and there was no operative death. The graft patency rate was 92.9% and the mean EF rose significantly from 0.37 to 0.53 after surgery (P less than 0.05). There was one late death, the 4-year actuarial survival rate being 88.9%. Of the eight long-term survivors, six (75%) were totally asymptomatic and only two had mild angina on exertion. This study confirmed that CABG for patients with depressed LV dysfunction can be performed safely with an acceptably low operative mortality, a significant improvement of LV function, and excellent long-term results.

Entities:  

Mesh:

Year:  1992        PMID: 1392339     DOI: 10.1007/bf00308736

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

1.  Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium.

Authors:  M T Partington; C Acar; G D Buckberg; P L Julia
Journal:  J Thorac Cardiovasc Surg       Date:  1989-04       Impact factor: 5.209

2.  Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries.

Authors:  M T Partington; C Acar; G D Buckberg; P Julia; E R Kofsky; H I Bugyi
Journal:  J Thorac Cardiovasc Surg       Date:  1989-04       Impact factor: 5.209

3.  Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment.

Authors:  R F Yatteau; R H Peter; V S Behar; A G Bartel; R A Rosati; Y Kong
Journal:  Am J Cardiol       Date:  1974-10-03       Impact factor: 2.778

4.  Coronary artery bypass grafts for congestive heart failure. A report of experiences with 40 patients.

Authors:  F C Spencer; G E Green; D A Tice; E Wallsh; N L Mills; E Glassman
Journal:  J Thorac Cardiovasc Surg       Date:  1971-10       Impact factor: 5.209

5.  Ischemic cardiomyopathy: medical versus surgical treatment.

Authors:  S L Faulkner; W S Stoney; W C Alford; C S Thomas; G R Burrus; R A Frist; H L Page
Journal:  J Thorac Cardiovasc Surg       Date:  1977-07       Impact factor: 5.209

6.  [Retrograde cardioplegia as a method of myocardial protection during aorto-coronary bypass].

Authors:  T Okubo; T Sakurada; R Hoshino; H Atsumi; S Sekine; M Ishii; S Saito; M Sato; T Abe
Journal:  Kyobu Geka       Date:  1984-10

7.  Bypass graft surgery in severe left ventricular dysfunction.

Authors:  C Hellman; D H Schmidt; M L Kamath; J Anholm; F Blau; W D Johnson
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

8.  Effect of coronary arterial bypass surgery on exercise-induced ventricular arrhythmias. Long-term follow-up of a prospective randomized study.

Authors:  K L Lehrman; A G Tilkian; H N Hultgren; R E Fowles
Journal:  Am J Cardiol       Date:  1979-11       Impact factor: 2.778

9.  Survival of medically treated patients in the coronary artery surgery study (CASS) registry.

Authors:  M B Mock; I Ringqvist; L D Fisher; K B Davis; B R Chaitman; N T Kouchoukos; G C Kaiser; E Alderman; T J Ryan; R O Russell; S Mullin; D Fray; T Killip
Journal:  Circulation       Date:  1982-09       Impact factor: 29.690

10.  Results of coronary artery surgery in patients with poor left ventricular function (CASS).

Authors:  E L Alderman; L D Fisher; P Litwin; G C Kaiser; W O Myers; C Maynard; F Levine; M Schloss
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.